Contact hours available until 12/31/2023.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online NCPD evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:
The author(s), editor, editorial board, content reviewers, and education director reported no actual or potential conflict of interest in relation to this nursing continuing professional development article.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
This educational activity is provided by the Society of Urologic Nurses and Associates (SUNA).

The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556.

This article was reviewed and formatted for nursing continuing professional development credit by Michele Boyd, MSN, RN, NPD-BC, SUNA Education Director.

Learning Outcome:
After completing this education activity, the learner will be able to discuss Botox injection as a third-line option for treating urinary symptoms, including frequency, urgency, urgency incontinence, and neurogenic overactive bladder.

Ahmed El-Zawahry MD

Appearances